ScienceDex / Researcher record
Marugan, Juan
- National Center for Advancing Translational Sciences (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Sustained Excellence
- Top 5% Funded
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $3,420,000 | 30 | #1,193 |
| 2016 | $4,841,548 | 23 | #616 |
| 2017 | $3,863,782 | 17 | #830 |
| 2018 | $4,096,702 | 19 | #791 |
| 2019 | $5,750,630 | 27 | #510 |
| 2021 | $5,717,964 | 18 | #566 |
| 2022 | $7,319,180 | 21 | #399 |
| 2023 | $4,878,110 | 19 | #762 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY201530 records
- FY201623 records
- FY201717 records
- FY201819 records
- FY201927 records
- FY2021 · selected18 records
- FY202221 records
- FY202319 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Marugan, Juan as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000083-07ZIAContact PIIdentification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$350.7Kaward amount
- 1ZIATR000086-07ZIAContact PIIdentification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent$350.7Kaward amount
- 1ZIATR000096-07ZIAContact PIPAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$350.7Kaward amount
- 1ZIATR000200-07ZIAContact PIKinetic High Throughput Screening for Agonists and Inhibitors of the TRPML1 Ion channel$350.7Kaward amount
- 1ZIATR000201-07ZIAContact PIIdentification of Modulators of the N370S Mutant Form of Glucocerebrosidase as a Potential Therapy for Gaucher Disease$350.7Kaward amount
- 1ZIATR000203-07ZIAContact PIHTS to Identify Inhibitors of c-Abl kinase for the Potential Treatment of Alzheimer's Disease$350.7Kaward amount
- 1ZIATR000207-07ZIAContact PIDeveloping inhibitors for PIP4Kgamma for Huntington's disease$350.7Kaward amount
- 1ZIATR000208-07ZIAContact PIProgression of Metarrestin that Reduces PNC Prevalence and Elucidation of its Mechanism of Action$350.7Kaward amount
- 1ZIATR000209-07ZIAContact PISmall molecule agonists of the relaxin 1 receptor$350.7Kaward amount
- 1ZIATR000212-07ZIAContact PIDiscovery of Novel Modulators of the Human D2 Dopamine Receptor$350.7Kaward amount
+8 more grants not shown.
Award organization
Organizations that administered FY2021 awards listing Marugan, Juan as a PI.
FY2021 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardNational Center for Advancing Translational Sciences
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015$2M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #1193
- 2015Entered Top 25% NationallyRanked #1193
- 2015Entered Top 10% NationallyRanked #1193
- 2016$5M Cumulative Funding
- 2016Entered Top 5% NationallyRanked #616
- 2017$10M Cumulative Funding
- 2021$25M Cumulative Funding